Gemtesa and Hot flush - a phase IV clinical study of FDA data

Summary:

Hot flush is reported as a side effect among people who take Gemtesa (vibegron), especially for people who are 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Hypertonic bladder.

The phase IV clinical study analyzes which people have Hot flush when taking Gemtesa. It is created by eHealthMe based on reports of 2,622 people who have side effects when taking Gemtesa from the FDA, and is updated regularly.

What is Gemtesa?

Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.

What is Hot flush?

Hot flush (sudden feelings of heat) is found to be associated with 1,768 drugs and 2,343 conditions by eHealthMe. Check the latest studies of Hot flush.

On Jul, 13, 2026

2,622 people reported to have side effects when taking Gemtesa.
Among them, 30 people (1.14%) have Hot flush.

Among these 30 people:

How long have people been on Gemtesa when they have Hot flush? *

What is the age of people who have Hot flush when taking Gemtesa? *

What are other drugs people take besides Gemtesa? *

What are other side effects people have besides Hot flush? *

Rashes (redness): 5 people, 16.67%
Skin Blushing/flushing (a sudden reddening of the face, neck): 3 people, 10.00%
Hyperhidrosis (abnormally increased sweating): 3 people, 10.00%
Body Temperature Increased: 2 people, 6.67%
Headache (pain in head): 2 people, 6.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 6.67%
Weight Increased: 1 person, 3.33%
Excessive Or Unwanted Hair In Women: 1 person, 3.33%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 3.33%
Feeling Hot: 1 person, 3.33%

What are the existing conditions these people have? *

Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 9 people, 30.00%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 6.67%
Parkinson's Disease: 2 people, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%
Micturition Urgency (urgency to pass the urine): 2 people, 6.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 3.33%
Urge Incontinence (urinary incontinence): 1 person, 3.33%
Gait Disturbance: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gemtesa and have Hot flush?

- Check whether Hot flush is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemtesa:

Gemtesa (2,648 reports)

Hot flush treatments and more:

Hot flush (91,208 reports)

Browse all side effects of Gemtesa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hot flush:

Hot flush (1,768 drugs)

Browse all the conditions that are associated with Hot flush:

Hot flush (2,343 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vibegron (the active ingredients of Gemtesa) and Gemtesa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.